Polar Capital Holdings’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$61.2M	Buy	3,050,294 +685,000	+29%	+$13.7M	0.32%	78
2025 Q1	$46.5M	Sell	2,365,294 -24,374	-1%	-$480K	0.28%	99
2024 Q4	$53.8M	Buy	2,389,668 +1,739,668	+268%	+$39.1M	0.3%	88
2024 Q3	$16.6M	Hold	650,000	–	–	0.08%	160
2024 Q2	$15.2M	Buy	+650,000	New	+$15.2M	0.09%	159